William Lynn - Concepedia

Author

William Lynn

Also Known As

W A Lynn, W Lynn, W. A. Lynn, W. Lynn, W.A Lynn, W.A. Lynn, WILLIAM A LYNN, William A Lynn, William A. Lynn, William Lynn

Publications

1.6K

Citations

H-Index

Concepts

All Affiliations

University College London Moorfields Eye Hospital Ealing Hospital Moorfields Eye Hospital NHS Foundation Trust Northwick Park Hospital

About

William Lynn is an author at University College London specializing in medicine, microbiology, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	9	9	244
2	Immunology	3	3	99
3	Health Sciences	1	1	11
4	Biochemistry	1	1	16
5	Hepatology	1	1	19

William Lynn

Publications

853

Citations

H-Index

Page 1

	Year	Citations
Prognostic value of interferon-γ release assays and tuberculin skin test in predicting the development of active tuberculosis (UK PREDICT TB): a prospective cohort study Ibrahim Abubakar, Francis Drobniewski, Jo Southern, The Lancet Infectious Diseases	2018	176
Lipopolysaccharide-induced stimulation of CD11b/CD18 expression on neutrophils. Evidence of specific receptor-based response and inhibition by lipid A-based antagonists William Lynn, C R Raetz, N Qureshi, The Journal of Immunology	1991	147
Neither CD14 nor serum is absolutely necessary for activation of mononuclear phagocytes by bacterial lipopolysaccharide William Lynn, Yuchen Liu, Douglas T. Golenbock Infection and Immunity	1993	123
FACTORS DETERMINING VISUAL OUTCOME IN ENDOGENOUS CANDIDA ENDOPHTHALMITIS Ahmed B. Sallam, Simon Taylor, Aldrin Khan, Retina	2012	95
Clinical utility of existing and second-generation interferon-γ release assays for diagnostic evaluation of tuberculosis: an observational cohort study Hilary Whitworth, Amarjit Badhan, Aime Boakye, The Lancet Infectious Diseases Diagnostic EvaluationPulmonary TuberculosisClinical UtilityImmunodeficienciesTuberculosis Prevention	2019	76
Pegylated interferon-α-2b reduces corticosteroid requirement in patients with Behçet’s disease with upregulation of circulating regulatory T cells and reduction of Th17 Susan Lightman, Simon Taylor, Catey Bunce, Annals of the Rheumatic Diseases	2014	68
Treatment of adenoviral pneumonitis with intravenous ribavirin and immunoglobulin. Ian Sabroe, J F McHale, Dereck Tait, Thorax Year Old WomanAntiviral TherapyPharmacotherapyAntiviral DrugNormal Human Immunoglobulin	1995	42
Chickenpox pneumonia: experience with antiviral treatment. Richard Davidson, William Lynn, Patrick Savage, Thorax VaccinationChickenpox PneumoniaAntiviral TherapyVirologyInfectious Respiratory Disease	1988	40
Predicting drug-induced liver injury from anti-tuberculous medications by early monitoring of liver tests Benjamin Patterson, Aula Abbara, Simon M. Collin, Journal of Infection Drug SafetyHepatologyLiver TestsPharmacologyLaboratory Medicine	2020	19
Glycopeptide Resistance in Gram-positive Bacteria D. C. E. Speller, William Lynn, Thomas R. Rogers Clinical Microbiology and Infection Gram-negative BacteriologyAntimicrobial Resistance GeneBiochemistryGlycopeptide ResistanceMicrobiology	1995	16

Page 1